Integrated Metabolomic and Transcriptomic Analysis Revealed the Mechanism of BHPF Exposure in Endometrium

Xin Tan, Nengyong Ouyang, Wenjun Wang, Junting QiuToxics 2025 · DOI

TL;DR

This study uses integrated metabolomics and transcriptomics to reveal how Fluorene-9-bisphenol (BHPF), a common BPA substitute, affects human endometrial cells. Low-dose BHPF appears to trigger immune responses, while high-dose exposure disrupts cell viability by altering purine metabolism and key genes.

What Problem Does This Paper Address?

Bisphenol A (BPA) has faced restrictions due to its endocrine-disrupting properties. Fluorene-9-bisphenol (BHPF) has emerged as a popular substitute in various consumer products, including food and beverage containers. While BHPF has been detected in human serum and environmental samples, its specific impact on human endometrial epithelial cells and the underlying molecular mechanisms remain largely unknown. This paper aims to fill this knowledge gap by investigating how different concentrations of BHPF affect these cells and by employing multi-omics approaches to uncover the cellular and molecular responses.

Methods

The researchers utilized a combination of experimental and computational techniques:

  • Cell Culture: Human endometrial adenocarcinoma Ishikawa cells were used as an in vitro model.
  • BHPF Exposure: Cells were exposed to varying concentrations of BHPF (ranging from 0.5 µM to 100 µM) for 48 hours.
  • Cell Viability Assay: The CCK-8 assay was employed to assess the impact of BHPF on cell survival and proliferation.
  • Nontargeted Metabolomics (LC-MS/MS): This technique was used to identify and quantify changes in metabolites within the endometrial cells.
  • Transcriptomic Analysis (RNA Sequencing): High-throughput sequencing was performed to analyze gene expression profiles.
  • Bioinformatics Analysis:
    • Metabolomics: Multivariate analysis (PCA, OPLS-DA) and pathway enrichment analysis (KEGG) were used to identify differentially expressed metabolites (DEMs) and their associated pathways.
  • Transcriptomics: Differential gene expression analysis was conducted to identify differentially expressed genes (DEGs), followed by GO and KEGG pathway enrichment analyses.
  • Joint Analysis: Integrated analysis of metabolomic and transcriptomic data was performed to identify correlations between metabolites and genes and to pinpoint key pathways affected by BHPF.

Datasets

Not discussed in the paper. The study generated its own metabolomic and transcriptomic data from cell cultures.

Key Insights and Ideas

  • Concentration-Dependent Effects: BHPF's impact on endometrial cells is clearly dose-dependent. Low concentrations trigger immune-related responses, while higher concentrations lead to significant cytotoxicity.
  • Immune System Activation at Low Doses: Low-dose BHPF (0.5 µM) appears to activate pathways related to primary immunodeficiency and the B-cell receptor signaling pathway, involving key genes like IL7R and PTPRC. This suggests an initial immune stress response.
  • Metabolic Disruption at High Doses: High-dose BHPF (5 µM) significantly impairs cell viability by disrupting purine metabolism. This involves dysregulation of genes like PGM1, PDE3B, AK9, and ENTPD8.
  • Taurine Depletion: A reduction in taurine levels was observed at both low and high BHPF concentrations. Taurine is known for its antioxidant and anti-inflammatory roles, suggesting that BHPF exposure may compromise the cells' ability to maintain immune homeostasis and protect against oxidative damage.
  • Interplay of Metabolites and Genes: The integrated multi-omics approach successfully linked specific metabolic changes with altered gene expression, providing a more holistic understanding of BHPF's mechanisms.

Key Results

  • BHPF exhibited a concentration-dependent inhibition of Ishikawa cell proliferation, with a median effective concentration (EC50) of 42.82 µM.
  • Low concentrations (0.5 µM) did not significantly affect cell viability but induced changes in immune-related pathways.
  • High concentrations (5 µM) led to a significant decrease in cell viability.
  • Metabolomics identified 178 differentially expressed metabolites (DEMs).
  • Transcriptomics identified 64 DEGs at 0.5 µM BHPF and 6799 DEGs at 5 µM BHPF, indicating a substantial transcriptional response at higher doses.
  • Joint analysis highlighted primary immunodeficiency and cell adhesion molecules as key pathways affected at low BHPF concentrations, and amino acid metabolism, energy metabolism, and signal transduction pathways at high concentrations.

Limitations and Future Work

  • In Vitro Model: The study used Ishikawa cells, a cell line derived from endometrial adenocarcinoma. While a standard model, it may not fully represent the complexity and heterogeneity of in vivo endometrial tissue. Future studies should consider animal models or human tissue samples for more profound exploration.
  • Short-Term Exposure: This study focused on acute exposure. Longer-term exposure studies, both in vitro and in vivo, are needed to understand chronic effects.
  • Cellular Heterogeneity: The study acknowledges the limitations of cell line models in representing cellular heterogeneity.
  • Future Directions: The authors suggest further research to investigate the regulatory mechanisms informed by the omics analysis results to elucidate underlying molecular mechanisms. They also propose exploring the effects of BHPF on cell adhesion, ion transport, and other associated functions.

Summary updated

Abstract

Fluorene-9-bisphenol (BHPF) has been increasingly used as a bisphenol A substitute in the synthesis of various products. Previous studies have suggested that BHPF can be released from plastic bottles into drinking water, and BHPF accumulation has been reported to cause various adverse effects in humans. Nevertheless, the impact of BHPF exposure on endometrial epithelial cells remains largely unexplored. Here, we investigated the effects of exposure to different concentrations of BHPF on endometrial cells and used integrated metabolomic and transcriptomic methods to elucidate the underlying molecular mechanisms. Our results revealed significant associations between specific metabolites and genes, indicating that low-concentration exposure to BHPF affects endometrial epithelial cells by targeting pathways related to primary immunodeficiency, in which the key genes are <i>IL7R</i> and <i>PTPRC</i>. High-concentration exposure to BHPF decreased cell viability by regulating the purine metabolism pathway, as well as dysregulating the expression of <i>PGM1</i>, <i>PDE3B</i>, <i>AK9,</i> and <i>ENTPD8</i>. Our study highlights that the health risk of BHPF exposure to endometrial epithelial cells is concentration-dependent and that integrated analysis of metabolomic and transcriptomic data not only revealed the biological effects of BHPF and its underlying mechanisms, but also provided key candidate target genes for further exploration.
BibTeX
@inproceedings{tan2025integrated,
  author = {Xin Tan and Nengyong Ouyang and Wenjun Wang and Junting Qiu},
  title = {{Integrated Metabolomic and Transcriptomic Analysis Revealed the Mechanism of BHPF Exposure in Endometrium}},
  booktitle = {Toxics},
  year = {2025},
  doi = {10.3390/toxics13020100},
}
Figure